When and why device manufacturers should use postmarket data to support PMA requirements.
This whitepaper covers the key takeaways from the FDA’s final guidance explaining the best balance between premarket and postmarket data collection during PMA reviews.
Instructor Larry Stevens, RAC, has held almost every field position within the FDA during his 21-year career with the Agency and leverages personal insights to help device manufacturers ensure all PMA requirements are met.
You’ll learn:
290 Turnpike Road, Suite 200
Westborough, MA 01581
(508) 926-8330
info@thefdagroup.comProprietary talent selection of former FDA and industry professionals amplified by a corporate culture of responsiveness and execution.
290 Turnpike Road, Suite 200
Westborough, MA 01581
US Toll-Free: 1-833-FDA-GROUP
International: +001 508 926 8330
The FDA Group will not be liable for any errors or omissions in this information nor for the availability of this information. The owner will not be liable for any losses, injuries, or damages from the display or use of this information. Privacy Policy.